HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
WVE
Wave Life Sciences Ltd.
There isn't enough reported data to score WVE yet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
WVE Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
WVE's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
WVE PE Valuation
WVE has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
WVE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Stable | |
| -- | |
| Limited | |
| Low |
Analysts expect WVE's losses to grow, with revenue holding steady. However, they disagree widely on these estimates.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has the edge over WVE on earnings, with more consistent year-over-year improvement.
WVE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.06 | -$0.40 |
| Q2 2026 | -$1.08 | -$0.27 |
| Q1 2026 | -$1.05 | -$0.30 |
| Q4 2025 | -$1.21 | -$0.51 |
| Q3 2025 | -$0.66 | +$0.44 |
| Q2 2025 | -$0.81 | -$0.25 |
| Q1 2025 | -$0.75 | -$0.24 |
| Q4 2024 | -$0.70 | -$0.16 |
WVE is still losing money, but far less than before: $1.06 per share over the past year, against $5.73 at its worst in early 2020.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the stronger quarterly revenue trend. Revenue is up 49% for HIMS versus up 43% for WVE.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over WVE on profitability, with a higher operating margin.
WVE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $2.3M | -74% |
| Q1 2026 | $38.2M | +317% |
| Q2 2025 | $8.7M | -56% |
| Q1 2025 | $9.2M | -27% |
| Q2 2024 | $19.7M | -11% |
| Q1 2024 | $12.5M | -3% |
| Q4 2023 | $29.1M | +2245% |
| Q3 2023 | $49.2M | +17168% |
WVE's revenue is recovering but still below its 2023 peak: $13M last quarter, up 43% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -502% | N/A |
| Q2 2026 | -3248% | -2642 points |
| Q1 2026 | -82% | +461 points |
| Q2 2025 | -606% | -429 points |
| Q1 2025 | -543% | -268 points |
| Q2 2024 | -178% | -72 points |
| Q1 2024 | -275% | -41 points |
| Q4 2023 | -64% | +3452 points |
WVE's operating margin was −502% last quarter, up 41 points from the same quarter a year ago.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over WVE on cash generation, producing positive trailing cash flow while its opponent burns cash.
WVE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$60.2M | -$15.2M |
| Q2 2026 | -$54.5M | -$8.1M |
| Q1 2026 | -$60M | +$3.2M |
| Q4 2025 | -$33.8M | +$10M |
| Q3 2025 | -$44.9M | +$1.9M |
| Q2 2025 | -$46.3M | -$18.8M |
| Q1 2025 | -$63.2M | -$29.4M |
| Q4 2024 | -$43.7M | -$10.1M |
WVE has burned cash in almost every quarter: −$208M over the past year, against −$198M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over WVE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
WVE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +214K shares |
| 1 year | +22% | +36.5M shares |
| 3 years | +91% | +97.2M shares |
| 5 years | +303% | +154M shares |
| Available history | +503% | +170M shares |
WVE has 204M diluted shares, up 22% from a year ago.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
WVE Net Leverage
WVE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
WVE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.2 | Oversold |
| Stochastic | 9.8 | Oversold |
WVE's weekly RSI is 29 (oversold) and its Stochastic is 10 (oversold).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
WVE PE vs Healthcare Sector
WVE has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
WVE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.43 | 8.2% below |
| 20 week MA | $4.64 | 32% below |
| 50 week MA | $8.10 | 61% below |
| 100 week MA | $8.32 | 62% below |
| 200 week MA | $7.13 | 56% below |
WVE is in a downtrend: it's below all five of its weekly moving averages, and 56% below its 200-week average.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS has the edge over WVE on returns for 2026, with the stronger performance.
WVE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15.8 | $8.91 | -44% |
| 2021 | $8.91 | $3.70 | -58% |
| 2022 | $3.70 | $6.51 | +76% |
| 2023 | $6.51 | $5.05 | -22% |
| 2024 | $5.05 | $12.9 | +155% |
| 2025 | $12.9 | $17.8 | +38% |
| 2026 YTD | $17.8 | $3.15 | -82% |
WVE's yearly returns have swung widely, from +155% in 2024 to −58% in 2021. It's down 82% so far in 2026.